MaxiVAX

OverviewSuggest Edit

MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. The company combines a vaccination process against the complete tumor cell with an immune system-boosting agent with its novel immunotherapy technology, thereby enabling cancer patients to get access to more treatment options.
TypePrivate
Founded2013
HQGenève, CH
Websitemaxivax.ch

Locations

MaxiVAX is headquartered in
Genève, Switzerland

Location Map

Latest Updates

Employees (est.) (Nov 2020)6
Cybersecurity ratingCMore

MaxiVAX Office Locations

MaxiVAX has an office in Genève
Genève, CH (HQ)
Rue de l'Athénée 24
Show all (1)

MaxiVAX Financials and Metrics

Summary Metrics

Founding Date

2013

MaxiVAX total Funding

$8.1 m

MaxiVAX latest funding size

$5.01 m

Time since last funding

a year ago
MaxiVAX's latest funding round in November 2019 was reported to be $5 m. In total, MaxiVAX has raised $8.1 m
Show all financial metrics

MaxiVAX Cybersecurity Score

Cybersecurity ratingPremium dataset

C

75/100

SecurityScorecard logo

MaxiVAX Online and Social Media Presence

Embed Graph

MaxiVAX Frequently Asked Questions

  • When was MaxiVAX founded?

    MaxiVAX was founded in 2013.

  • How many employees does MaxiVAX have?

    MaxiVAX has 6 employees.

  • Who are MaxiVAX competitors?

    Competitors of MaxiVAX include FoRx Therapeutics, Werewolf Therapeutics and Verseau Therapeutics.

  • Where is MaxiVAX headquarters?

    MaxiVAX headquarters is located at Rue de l'Athénée 24, Genève.

  • Where are MaxiVAX offices?

    MaxiVAX has an office in Genève.

  • How many offices does MaxiVAX have?

    MaxiVAX has 1 office.